878PTiNivo - tivozanib combined with nivolumab: Safety and efficacy in patients with metastatic renal cell carcinoma (mRCC). (23rd October 2018) - Barthelemy, P; Escudier, B; Ravaud, A; Negrier, S; Needle, M N; Albiges, L